A South Carolina judge declared a mistrial in a case against Johnson & Johnson alleging that exposure to asbestos in its Johnson’s Baby Powder caused a woman’s fatal cancer. Jurors in Darlington County state court were unable to reach a …
Johnson & Johnson lost a second trial linking baby powder use to deadly asbestos cancer and jurors must next decide whether to punish the company on top of their award of $21.7 million in damages. Jurors in state court in …
Billionaire investor Carl Icahn sued the directors of AmTrust Financial Services Inc., Chief Executive Officer Barry Zyskind and the family that controls the insurer to challenge a plan to take the insurer private, arguing it will shortchange investors. Icahn, who …
Drug companies are in no rush to finance a solution to the opioid epidemic. Companies including Johnson & Johnson and McKesson Corp. are preparing to take their chances in court rather than pay billions of dollars to settle lawsuits blaming …
Johnson & Johnson persuaded an appeals court to throw out a $151 million award over its Pinnacle artificial hips in a ruling that will affect thousands of lawsuits over the devices. A judge’s error in allowing hip recipients’ lawyers to …
Johnson & Johnson and a talc-mining company were ordered by jurors to pay $80 million in punitive damages for hiding that their products, including J&J’s iconic baby powder, had been tainted by asbestos and posed a cancer risk. The New …
Jurors are set to weigh an investment banker’s claims that using Johnson & Johnson’s baby powder for more than 30 years caused him to develop a deadly cancer linked to asbestos. A New Jersey jury will begin deciding Wednesday whether …
Purdue Pharma LP’s decision to stop promoting its opioid drugs to doctors is being hailed as the first result of a judge’s push for concrete solutions to a nationwide epidemic, even though the company says the move has nothing to …
The judge overseeing U.S. cities’ and counties’ lawsuits against makers of opioid painkillers said he hopes a sweeping resolution can be worked out by the end of the year that will have a “meaningful impact” on the burgeoning drug epidemic. …
Uber Technologies Inc. directors were accused of failing to properly review the ride-sharing company’s $680 million acquisition of a self-driving technology firm that wound up being accused of stealing trade secrets from a unit of Alphabet Inc. Uber’s board recklessly …
